Clinical Trial Update: A Phase 1-2 of ST316 With Selected Advanced Unresectable and Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1-2 clinical trial evaluating ST316 for advanced unresectable and metastatic solid tumors, including colon cancer, is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer

Drugs mentioned

• ST316

Snippet

Sponsor: Sapience Therapeutics | Conditions: Colon Cancer, Metastatic Colon Cancer | Phase 1 | Status: RECRUITING